Treatment of Inflammatory Bowel Disease with Biologics
72 were initiated on IFX and 11 on mesalamine for 1 year duration. The majority (54%) of patients treated with IFX had endoscop ...
73 appears as efficacious as immediate initiation postoperatively and may reduce costs and side effects. However, nearly half of ...
74 therapy immediately after surgery. If a patient can tolerate metronidazole, this is reasonable to combine with immunomodulato ...
75 endoscopic evaluation within 6–12 months of surgery and subsequent initiation of weight-based AZA in presence of endoscopic r ...
76 been definitively established as superior to either agent alone. Thus, while signifi- cant inroads have been made in the unde ...
77 Andreoli A, Cerro P, Falasco G, Giglio LA, Prantera C. Role of ultrasonography in the diagno- sis of postsurgical recurrence ...
78 Malireddy K, Larson DW, Sandborn WJ, Loftus EV, Faubion WA, Pardi DS, et al. Recurrence and impact of postoperative prophyla ...
79 Regueiro M, El-Hachem S, Kip KE, Schraut W, Baidoo L, Watson A, et al. Postoperative infliximab is not associated with an i ...
© Springer International Publishing AG 2018 81 A.S. Cheifetz, J.D. Feuerstein (eds.), Treatment of Inflammatory Bowel Disease wi ...
82 for low birth weight, preterm birth, and stillbirth [ 8 – 13 ]. Preconception counseling about the importance of obtaining di ...
83 IgG1 monoclonal antibody to TNFα approved for use in ulcerative colitis. As more recent studies have shown that earlier treat ...
84 longer detectable [ 23 ]. At the time of birth, the median ratio of cord blood to maternal drug concentration for IFX was 160 ...
85 which were healthy without any congenital defects or adverse events compared to 90.7% (68/75) live births and 85.3% (58/68) o ...
86 with Crohn’s disease, 118 in women with rheumatic disease) exposed to CZP were obtained through review of a large pharmaceut ...
87 Several studies have found an increased risk for SA following anti-TNF expo- sure during pregnancy. Using the British Society ...
88 phenotype (P = 0.004), and prior pregnancy complications (P = 0.007), while the only risk factor associated with newborn comp ...
89 Effect of Anti-TNFα Medications on Newborn Outcomes Intrauterine anti-TNF exposure, particularly later in pregnancy, has rais ...
90 no other complications. Cellular immunity was noted to be normal in all infants, and response to vaccination, which was evalu ...
91 predict undetectable drug concentrations at birth.” [ 26 ] However, despite the vari- ability in cord blood drug concentratio ...
92 Looking specifically at NAT exposure during the third trimester, a recent case series of 13 pregnancies in 12 women with seve ...
«
1
2
3
4
5
6
7
8
9
10
»
Free download pdf